Observational
Specific KCNQ1 mutations identified in Saudi Arabian JLNS patients can facilitate region-specific cascade screening for long QT syndrome.
May support targeted KCNQ1 screening in Saudi JLNS families; leaves open validation in larger cohorts before practice change.
We sought to explore the genotype-phenotype of Jervell and Lange-Nielsen syndrome (JLNS) patients in Saudi Arabia. We have also assessed the plausible effect of consanguinity into the pathology of JLNS. Six families with at least one JLNS-affected member attended our clinic between 2011 and 2013. Retrospective and prospective clinical data were collected and genetic investigation was performed. Pathogenic mutations in the KCNQ1 gene were detected in all JLNS patients. The homozygous mutations detected were Leu273Phe, Asp202Asn, Ile567Thr, and c.1486_1487delCT and compound heterozygous mutations were c.820_ 830del and c.1251+1G>T. All living JLNS patients except one had a QTc of >500 ms and a history of recurrent syncope. β-Blockers abolished the cardiac-related events in all patients except two siblings with homozygous Ile567Thr mutation. Four of the six mutations were originally reported in autosomal dominant long QT syndrome (LQTS) patients. Eighty percent of the heterozygote mutation carriers showed prolongation of QTc, but majority of these reported no symptoms attributable to arrhythmias. Mutations detected in this study will be advantageous in tribe and region-specific cascade screening of LQTS in Saudi Arabia.
No takes yet. Share an insight, caveat, or question.
Al‐Aama et al. (2013) conducted an observational in Jervell and Lange-Nielsen syndrome (JLNS). KCNQ1 gene mutations was evaluated on Detection of pathogenic mutations in the KCNQ1 gene and QTc prolongation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: